Sabby Management’s Sunshine Biopharma SBFM Stock Holding History

Sabby Management’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8	Closed	-$2.24K	–	58
2025 Q2	$2.24K	Buy	+8	New	+$2.34K	﹤0.01%	43
2024 Q3	–	Sell	-5	Closed	-$8.35K	–	58
2024 Q2	$8.35K	Buy	+5	New	+$47.7K	0.01%	38

Other funds holding SBFM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Sabby Management's SBFM Position: Q3 2025 in Review

Sabby Management sold out of Sunshine Biopharma (SBFM) in Q3 2025, closing a stake of 8 shares — an estimated $2.24K sold.

Sabby Management first reported a position in SBFM in Q2 2024 and held it in 2 quarters. The position peaked at $8.35K in Q2 2024. 9 funds tracked by Wall St. Rank hold SBFM as of Q3 2025.

Sabby Management reported no remaining Sunshine Biopharma position as of Q3 2025 after selling out during the quarter.
Sabby Management sold 8 Sunshine Biopharma shares in Q3 2025, an estimated $2.24K.
Sabby Management first reported a position in Sunshine Biopharma in Q2 2024 and held it in 2 quarters.
Sabby Management's Sunshine Biopharma position peaked at $8.35K in Q2 2024.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2025.

Based on Sabby Management's 13F filing for Q3 2025, filed 14 Nov 2025.